Publikasjonsliste for Meldingssystem for smittsomme sykdommer (MSIS)
Artikkel
|Oppdatert
Oversikt over forskningsartikler der data fra Meldingssystem for smittsomme sykdommer (MSIS) er brukt.
Forskere og andre kan be om tilgang til statistikk eller data fra Meldingssystem for smittsomme sykdommer (MSIS) og de andre helseregistrene som Folkehelseinstituttet er databehandlingsansvarlig for. Helseregistre er en unik kilde til kunnskap om befolkningens helse, årsaker til sykdom og kvaliteten på helse- og omsorgstjenestene.
Dette er en oversikt over artikler fra forskning hvor helseregistre er brukt som datakilde, publisert i vitenskapelige tidsskrift. Listene er basert på metodiske søk i internasjonale artikkeldatabaser. De vil kunne være ufullstendige, avhengig av hvordan kildeopplysningene er angitt i artiklene.
For å søke om tilgang til statistikk, data eller biologisk materiale fra helseregistre eller helseundersøkelser som Folkehelseinstituttet forvalter, må du benytte elektronisk søknadsskjema.
2023
- Amato E, Hyllestad S, Heradstveit P, Langlete P, Moen LV, Rohringer A, et al. Evaluation of the pilot wastewater surveillance for SARS-CoV-2 in Norway, June 2022 – March 2023. BMC Public Health 2023;23:1-13. DOI: 10.1186/s12889-023-16627-2 https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-023-16627-2
- Blix K, Laake I, Juvet L, Robertson AH, Caspersen IH, Mjaaland S, et al. Unexpected vaginal bleeding and COVID-19 vaccination in non-menstruating women. Science Advances 2023;9(38):eadg1391. https://pubmed.ncbi.nlm.nih.gov/37738335/
- Brunvoll SH, Nygaard AB, Fagerland MW, Holland P, Ellingjord-Dale M, Dahl JA, et al. Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection. Int J Infect Dis 2023;126:10-3. DOI: 10.1016/j.ijid.2022.11.009 https://pubmed.ncbi.nlm.nih.gov/36375693/
- Brynildsrud OB, Watle SV, Alfsnes K, Caugant DA. Invasive meningococcal disease in Norway in the two decades prior to the COVID-19 pandemic. Int J Infect Dis. 2023 Apr 6:S1201-9712(23)00136-4. doi: 10.1016/j.ijid.2023.04.005. Epub ahead of print. PMID: 37030654. https://pubmed.ncbi.nlm.nih.gov/37030654/
- Caspersen IH, Trogstad L, Galanti MR, Karvonen S, Pena S, Shaaban AN, et al. Current tobacco use and SARS-CoV-2 infection in two Norwegian population-based cohorts. BMC Public Health 2023;23(1):846. DOI: 10.1186/s12889-023-15822-5 https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-023-15822-5
- Danielsen AS, Elstrøm P, Eriksen-Volle HM, Hofvind S, Eyre DW, Kacelnik O, Bjørnholt JV. The epidemiology of multidrug-resistant organisms in persons diagnosed with cancer in Norway, 2008-2018: expanding surveillance using existing laboratory and register data. Eur J Clin Microbiol Infect Dis. 2023 Nov 18. doi: 10.1007/s10096-023-04698-3. Epub ahead of print. PMID: 37980302. https://pubmed.ncbi.nlm.nih.gov/37980302/
- Elgersma IH, Fretheim A, Elstrøm P, Aavitsland P. Association between Face mask use and the Risk of Infection With SARS-CoV-2 in the Community – A cohort study. Zenodo; 2023. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10728967/
- Elgersma IHC, Data c, Formal a, Methodology, Writing - original d, Writing r, et al. Association between face mask use and risk of SARS-CoV-2 infection: Cross-sectional study. Epidemiology & Infection March 2023;02(151). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10728967/
- Elgersma IHMA, Telle KP, Elstrom PP, Skagseth HMA, Kacelnik OMDP. Transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) between hospital workers and members of their household: Nationwide, registry-based, cohort study from Norway. Infect Control Hosp Epidemiol 2023;44(4):604-9. https://pubmed.ncbi.nlm.nih.gov/35485709/
- Godoy A, Grotting MW. Implementation and spillovers of local non-pharmaceutical interventions. Health Econ 2023;32(4):822-52. https://onlinelibrary.wiley.com/doi/10.1002/hec.4644
- Goren A, Mysterud A, Jore S, Viljugrein H, Bakka H, Vindenes Y. Demographic patterns in Lyme borreliosis seasonality over 25 years. Zoonoses Public Health. 2023 Jul 17. doi: 10.1111/zph.13073. Epub ahead of print. PMID: 37458418. https://pubmed.ncbi.nlm.nih.gov/37458418/
- Goren A, Viljugrein H, Rivrud IM, Jore S, Bakka H, Vindenes Y, Mysterud A. The emergence and shift in seasonality of Lyme borreliosis in Northern Europe. Proc Biol Sci. 2023 Feb 22;290(1993):20222420. doi: 10.1098/rspb.2022.2420. Epub 2023 Feb 22. PMID: 36809802. https://pubmed.ncbi.nlm.nih.gov/36809802/
- Harangen OR, Harstad I, Arnesen TM. Does tuberculosis contact tracing work as intended in Norway? A retrospective register-based cohort study of tuberculosis patients and contact tracing data from 2016 to 2021. NTNU; 2023. https://ntnuopen.ntnu.no/ntnu-xmlui/bitstream/handle/11250/3104652/no.ntnu%3Ainspera%3A146510447%3A34517882.pdf?sequence=1&isAllowed=y
- Hetlevik Ø, Knut-Arne W, Baste V, Emberland KE, Özgümüs T, Siri Eldevik H, et al. Prevalence and predictors of post-COVID-19 symptoms in general practice - a registry-based nationwide study. BMC Infect Dis 2023;23:1-11. DOI: 10.1186/s12879-023-08727-6 https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-023-08727-6
- Husby A, Gulseth HL, Hovi P, Hansen JV, Pihlström N, Gunnes N, Härkänen T, Dahl J, Karlstad Ø, Heliö T, Køber L. Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study. BMJ Medicine. 2023 Feb 1;2(1). http://dx.doi.org/10.1136/bmjmed-2022-000373
- Jore S, Viljugrein H, Hjertqvist M, Dub T, Mäkelä H. Outdoor recreation, tick borne encephalitis incidence and seasonality in Finland, Norway and Sweden during the COVID-19 pandemic (2020/2021). Infection Ecology & Epidemiology. 2023 Nov 18. https://doi.org/10.1080/20008686.2023.2281055
- Kjollesdal M, Magnusson K. Occupational risk of COVID-19 by country of birth. A register-based study. Journal of Public Health 2023;45(1):6-12. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522378/
- Kjollesdal MKR, Juarez SP, Aradhya S, Indseth T. Understanding the excess COVID-19 burden among immigrants in Norway. Journal of Public Health 2023;45(2):277-86. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992298/
- Langlete P, Tesli M, Veneti L, Starrfelt J, Elstrøm P, Meijerink H. Estimated vaccine effectiveness against SARS-CoV-2 Delta and Omicron infections among health care workers and the general adult population in Norway, August 2021–January 2022. Vaccine. 2023 May 10. https://doi.org/10.1016/j.vaccine.2023.05.022
- Leonhardt M, Bramness JG, Lien L. Incidence of SARS-CoV-2 and all-cause mortality in persons with co-occurring substance use disorder and mental illness during the pandemic: a Norwegian cohort study. Social psychiatry and psychiatric epidemiology 2023;28. DOI: 10.1007/s00127-023-02599-6 https://munin.uit.no/handle/10037/32060
- Ljungquist O, Haldorsen B, Pöntinen AK, Janice J, Josefsen EH, Elstrøm P, Kacelnik O; Norwegian Study Group on CPE; Sundsfjord A, Samuelsen Ø; Members of The Norwegian Study Group on CPE. Nationwide, population-based observational study of the molecular epidemiology and temporal trend of carbapenemase-producing Enterobacterales in Norway, 2015 to 2021. Euro Surveill. 2023 Jul;28(27):2200774. doi: 10.2807/1560-7917.ES.2023.28.27.2200774. PMID: 37410381. https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2023.28.27.2200774
- Magnus MC, Haberg SE, Carlsen EO, Kwong JC, Buchan SA, Fell DB. Pregnancy Status at the Time of Coronavirus Disease 2019 Vaccination and Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Clin Infect Dis 2023;76(1):57-65. https://fhi.brage.unit.no/fhi-xmlui/bitstream/handle/11250/3065593/Magnus_2022_Pre_2.pdf?sequence=3
- Malme KB, Ulstein K, Finbråten A-K, Wüsthoff LEC, Kielland KB, Hauge J, et al. Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway: A registry-based study. Int J Drug Policy 2023;116:104044-. DOI: 10.1016/j.drugpo.2023.104044 https://www.sciencedirect.com/science/article/pii/S0955395923000920?via%3Dihub
- Methi F, Gran JM, Valberg M, Kinge JM, Telle K, Magnusson K. Third dose mRNA vaccination against SARS-CoV-2 reduces medical complaints seen in primary care: a matched cohort study. BMC Med. 2023 Apr 26;21(1):157. doi: 10.1186/s12916-023-02870-2. PMID: 37101263. https://pubmed.ncbi.nlm.nih.gov/37101263/
- Mikkelsen MB, Husby O, Molden T, Mwaura DN, Olsen J, Kristensen NV, et al. Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting. Cost Effectiveness and Resource Allocation 2023;21:1-15. DOI: 10.1186/s12962-023-00458-4 https://resource-allocation.biomedcentral.com/articles/10.1186/s12962-023-00458-4
- Mynarek M, Vik T, Andersen GL, Brigtsen AK, Hollung SJ, Larose TL, Lydersen S, Olsen LC, Strøm MS, Afset JE. Mortality and neurodevelopmental outcome after invasive group B streptococcal infection in infants. Dev Med Child Neurol. 2023 Jun 12. doi: 10.1111/dmcn.15643. Epub ahead of print. PMID: 37306102. https://pubmed.ncbi.nlm.nih.gov/37306102/
- Orangzeb S, Watle SV, Caugant DA. Adherence to vaccination guidelines of patients with complete splenectomy in Norway, 2008-2020. Vaccine 2023;41(31):4579-85. DOI: 10.1016/j.vaccine.2023.06.034 https://pubmed.ncbi.nlm.nih.gov/37336662/
- Ortqvist AK, Magnus MC, Aabakke AJM, Urhoj SK, Vinkel Hansen A, Nybo Andersen A-M, et al. Severe COVID-19 during pregnancy in Sweden, Norway, and Denmark. Acta Obstet Gynecol Scand 2023;102(6):681-9. https://pubmed.ncbi.nlm.nih.gov/36928990/
- Ovrebotten T, Tholin B, Myhre PL, Stavem K. Lower incidence of new-onset heart disease following covid-19 compared to viral pneumonia despite more echocardiography. Eur Heart J 2023;44(Supplement_2). DOI: 10.1093/eurheartj/ehad655.890 https://academic.oup.com/eurheartj/article/44/Supplement_2/ehad655.890/7393388
- Paulsen KM, Vikse R, Soleng A, Edgar K, Lindstedt HEH, Dorenberg DH, et al. TBE in Norway. Tick-borne encephalitis - The Book 2023. DOI: 10.33442/26613980_12b24-6 https://tbenews.com/tbe/tbe12b24/
- Reme BA, Grøsland M, Gjefsen H, Magnusson K. Impact of the COVID-19 pandemic on sick leave among healthcare workers: a register-based observational study. Occup Environ Med. 2023 Apr 17:oemed-2022-108555. doi: 10.1136/oemed-2022-108555. Epub ahead of print. PMID: 37068949. https://pubmed.ncbi.nlm.nih.gov/37068949/
- Rubaye MAL, Janice J, Bjornholt JV, Kacelnik O, Haldorsen BC, Nygaard RM, et al. The population structure of vancomycin-resistant and-susceptible Enterococcus faecium in a low-prevalence antimicrobial resistance setting is highly influenced by circulating global hospital-associated clones. Microbial Genomics 2023;9(12) (no pagination). DOI: 10.1099/mgen.0.001160 https://pubmed.ncbi.nlm.nih.gov/38112685/
- Shafquat MBS, Angulo FJP, Pilz AP, Moisi JCP, Stark JHP. The Incidence of Lyme Borreliosis Among Children. Pediatr Infect Dis J 2023;42(10):867-74. https://journals.lww.com/pidj/fulltext/2023/10000/the_incidence_of_lyme_borreliosis_among_children.7.aspx
- Skagseth H, Danielsen AS, Kacelnik O, Trondsen UJ, Berg TC, Sorknes NK, Eriksen-Volle HM. Clusters of healthcare-associated SARS-CoV-2 infections in Norwegian hospitals detected by a fully automatic register-based surveillance system. J Hosp Infect. 2023 Mar 11:S0195-6701(23)00074-9. doi: 10.1016/j.jhin.2023.02.014. Epub ahead of print. PMID: 36913981. https://pubmed.ncbi.nlm.nih.gov/36913981/
- Skagseth H, Jørgensen SB, Reilly J, Kacelnik O. A new method for near real-time, nationwide surveillance of nosocomial COVID-19 in Norway: providing data at all levels of the healthcare system, March 2020 to March 2022. Euro Surveill. 2023 Mar;28(12). doi: 10.2807/1560-7917.ES.2023.28.12.2200493. PMID: 36951784. https://pubmed.ncbi.nlm.nih.gov/36951784/
- Solveig Engebretsen hoo, Alfonso Diz-Lois Palomares hoo, Rø G, Anja Bråthen Kristoffersen hoo, Jonas Christoffer Lindstrøm hoo, Kenth Engø-Monsen hoo, et al. A real-time regional model for COVID-19: Probabilistic situational awareness and forecasting. PLoS Comput Biol 2023;19(1). DOI: 10.1371/journal.pcbi.1010860 https://www.medrxiv.org/content/10.1101/2023.08.16.23294112v1.full.pdf
- Tholin B, Ghanima W, Selle ML, Stavem K. Incidence and determinants of venous thromboembolism over 90 days in hospitalized and nonhospitalized patients with COVID-19. J Intern Med 2023;294(6):721-9. https://onlinelibrary.wiley.com/doi/10.1111/joim.13706
- Veneti L, Berild JD, Watle SV, Starrfelt J, Greve-Isdahl M, Langlete P, Bøås H, Bragstad K, Hungnes O, Meijerink H. Effectiveness of BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron infection in adolescents, Norway, August 2021 to January 2022. Int J Infect Dis. 2023 Mar 7:S1201-9712(23)00080-2. doi: 10.1016/j.ijid.2023.03.004. Epub ahead of print. PMID: 36893942 https://pubmed.ncbi.nlm.nih.gov/36893942/
- Whittaker R, Toikkanen S, Dean K, Lyngstad TM, Buanes EA, Kløvstad H, Paulsen TH, Seppälä E. A comparison of two registry-based systems for the surveillance of persons hospitalised with COVID-19 in Norway, February 2020 to May 2022. Euro Surveill. 2023 Aug;28(33):2200888. doi: 10.2807/1560-7917.ES.2023.28.33.2200888. PMID: 37589591. https://pubmed.ncbi.nlm.nih.gov/37589591/
2022
- Akselsen PE, Andersen CT, Caugant DAY, Dansie LS, Elstrøm P, Simonsen GS, et al. NORM/NORM-VET 2021: Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway. Veterinærinstituttet og Folkehelseinstituttet; 2022. Microsoft Word - NORM NORM-VET 2021 - Sikkerhetskopi 72 (uit.no)
- Arntzen SS, Gjefsen HM, Telle KE, Magnusson K, Størdal K, Håberg SE, Kinge JM. General practitioner visits after SARS-CoV-2 omicron compared with the delta variant in children in Norway: a prospective nationwide registry study. BMJ Paediatr 2022 Aug;6(1):e001502. doi: 10.1136/bmjpo-2022-001502. PMID: 36053662. https://pubmed.ncbi.nlm.nih.gov/36053662/
- Bahar E, Shamarina D, Sergerie Y, Mukherjee P. Descriptive Overview of Pertussis Epidemiology Among Older Adults in Europe During 2010-2020. Infect Dis Ther 2022;11(5):1821-38. DOI: 10.1007/s40121-022-00668-y Descriptive Overview of Pertussis Epidemiology Among Older Adults in Europe During 2010–2020 (nih.gov)
- Carlsen EOMD, Magnus MCP, Oakley LP, Fell DBP, Greve-Isdahl MMD, Kinge JMP, et al. Association of COVID-19 Vaccination During Pregnancy With Incidence of SARS-CoV-2 Infection in Infants. JAMA Internal Medicine 2022;182(8):825-31. 84614.pdf
- Danielsen AS, Cyr PR, Berg TC, Jønsberg E, Eriksen-Volle HM, Kacelnik O. Registerbasert overvåkning av covid-19 i sykehjem. Tidsskr Nor Legeforen. 11. mai 2022. doi: 10.4045/tidsskr.21.0906 https://tidsskriftet.no/2022/05/kort-rapport/registerbasert-overvakning-av-covid-19-i-sykehjem
- Fretheim A, Elgersma IH, Helleve A, Elstrøm P, Kacelnik O, Hemkens LG. Effect of Wearing Glasses on Risk of Infection With SARS-CoV-2 in the Community: A Randomized Clinical Trial. JAMA Netw Open 2022;5(12):e2244495-e. DOI: 10.1001/jamanetworkopen.2022.44495 Effect of Wearing Glasses on Risk of Infection With SARS-CoV-2 in the Community: A Randomized Clinical Trial - PubMed (nih.gov)
- Fretheim A, Ingeborg Hess E, Helleve A, Elstrom P, Kacelnik O, Hemkens LG. Glasses Against transmission of SARS-CoV-2 in the community (GLASSY): a pragmatic randomized trial. Cold Spring Harbor: Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 2022.
- Geretti AM, Mardh O, de Vries HJC, Winter A, McSorley J, Seguy N, et al. Sexual transmission of infections across Europe: appraising the present, scoping the future. Sex Transm Infect 2022;98(6):451-7.
- Gravningen K, Nymark P, Wyller TB, Kacelnik O. A new automated national register-based surveillance system for outbreaks in long-term care facilities in Norway detected three times more severe acute respiratory coronavirus virus 2 (SARS-CoV-2) clusters than traditional methods. Infect Control Hosp Epidemiol. 2022 Dec 16:1-7. doi: 10.1017/ice.2022.297. Epub ahead of print. PMID: 36524319. https://pubmed.ncbi.nlm.nih.gov/36524319/
- Grøsland M, Vilde Bergstad L, Telle K, Gjefsen HM. Has vaccination alleviated the strain on hospitals due to COVID-19? A combined difference-in-difference and simulation approach. BMC Health Serv Res 2022;22:1-11. DOI: 10.1186/s12913-022-08541-x Has vaccination alleviated the strain on hospitals due to COVID-19? A combined difference-in-difference and simulation approach | BMC Health Services Research | Full Text (biomedcentral.com)
- Hanquet G, Krizova P, Dalby T, Ladhani SN et al., incl. Winje BA, Vestrheim DF. Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe. Emerg Infect Dis. 2022 Jan;28(1):137-138. doi: 10.3201/eid2801.210734. PMID: 34932457. https://pubmed.ncbi.nlm.nih.gov/34932457/
- Ingeborg Hess E, Fretheim A, Indseth T, Munch AT, Live Bøe J, Christine Engh H. The Evaluation of a Social Media Campaign to Increase COVID-19 Testing in Migrant Groups: Cluster Randomized Trial. J Med Internet Res 2022. DOI: 10.2196/34544 https://clinicaltrials.gov/ct2/show/NCT04866589 Journal of Medical Internet Research - The Evaluation of a Social Media Campaign to Increase COVID-19 Testing in Migrant Groups: Cluster Randomized Trial (jmir.org)
- Ingrid Egeland C, Jyssum I, Tveter AT, Sexton J, Tran TT, Mjaaland S, et al. The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls—a prospective cohort study. BMC Med 2022;20:1-13. DOI: 10.1186/s12916-022-02587-8 The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls—a prospective cohort study | BMC Medicine | Full Text (biomedcentral.com)
- Jalali N, Brustad HK, Frigessi A, MacDonald EA, Meijerink H, Feruglio SL, Nygård KM, Rø G, Madslien EH, de Blasio BF. Increased household transmission and immune escape of the SARS-CoV-2 Omicron compared to Delta variants. Nat Commun. 2022 Sep 29;13(1):5706. doi: 10.1038/s41467-022-33233-9. PMID: 36175424. https://pubmed.ncbi.nlm.nih.gov/36175424/
- Kared H, Wolf A-S, Alirezaylavasani A, Ravussin A, Solum G, Tran TT, et al. Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults. Nature Communications 2022;13(1). DOI: 10.1038/s41467-022-31888-y Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults | Nature Communications
- Kjøllesdal M, Skyrud K, Gele A, Arnesen T, Kløvstad H, Diaz E, et al. The correlation between socioeconomic factors and COVID-19 among immigrants in Norway: a register-based study. Scand J Public Health 2022;50(1):52-60. DOI: 10.1177/14034948211015860
- Kjøllesdal MKR, Juarez SP, Aradhya S, Indseth T. Understanding the excess COVID-19 burden among immigrants in Norway. J Public Health (Oxf). 2022 Mar 14:fdac doi: 10.1093/pubmed/fdac033. Epub ahead of print. PMID: 35285905. https://pubmed.ncbi.nlm.nih.gov/35285905/
- Labberton AS, Godøy A, Elgersma IH, Strand BH, Telle K, Arnesen T, Nygård KM, Indseth T. SARS-CoV-2 infections and hospitalisations among immigrants in Norway-significance of occupation, household crowding, education, household income and medical risk: a nationwide register study. Scand J Public Health. 2022 Feb 14:14034948221075029. doi: 10.1177/14034948221075029. Epub ahead of print. PMID: 35164616. https://pubmed.ncbi.nlm.nih.gov/35164616/
- Lyngstad TM, Anja Bråthen K, Brita Askeland W, Steens A. Estimation of the incidence of hospitalization for non-invasive pneumococcal pneumonia in the Norwegian population aged 50 years and older. Epidemiol Infect 2022:1-21. DOI: 10.1017/S0950268822000607 Estimation of the incidence of hospitalisation for non-invasive pneumococcal pneumonia in the Norwegian population aged 50 years and older | Epidemiology & Infection | Cambridge Core
- Laake I, Skodvin SN, Blix K, Caspersen IH, Gjessing HK, Juvet LK, et al. Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian Cohort. J Infect Dis 2022;226(11):1924-33. Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian Cohort (nih.gov)
- Magnusson K, Kristoffersen DT, Dell'Isola A, Kiadaliri A, Turkiewicz A, Runhaar J, Bierma-Zeinstra S, Englund M, Magnus PM, Kinge JM. Post-covid medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants. Nat Commun. 2022 Nov 30;13(1):7363. doi: 10.1038/s41467-022-35240-2. PMID: 36450749. https://pubmed.ncbi.nlm.nih.gov/36450749/
- Magnusson Kr, Skyrud KDr, Suren Pp, Greve-Isdahl Msp, Stordal Kp, Kristoffersen DTs, et al. Healthcare use in 700 000 children and adolescents for six months after covid-19: before and after register based cohort study. BMJ January 2022;22(376). Healthcare use in 700 000 children and adolescents for six months after covid-19: before and after register based cohort study | The BMJ
- Methi F, Hart RK, Godoy AA, Jorgensen SB, Kacelnik O, Telle KE. Transmission of SARS-CoV-2 into and within immigrant households: nationwide registry study from Norway. J Epidemiol Community Health 2022;76(5):435-9. Transmission of SARS-CoV-2 into and within immigrant households: nationwide registry study from Norway - PubMed (nih.gov)
- Methi F, Hernæs KH, Katrine Damgaard S, Magnusson K. Pandemic trends in health care use: From the hospital bed to self-care with COVID-19. PLoS One 2022;17(3). DOI: 10.1371/journal.pone.0265812 Transmission of SARS-CoV-2 into and within immigrant households: nationwide registry study from Norway - PubMed (nih.gov).
- Methi F, Madslien EH. Lower transmissibility of SARS-CoV-2 among asymptomatic cases: evidence from contact tracing data in Oslo, Norway. BMC Med 2022;20:1-9. DOI: 10.1186/s12916-022-02642-4 Lower transmissibility of SARS-CoV-2 among asymptomatic cases: evidence from contact tracing data in Oslo, Norway | BMC Medicine | Full Text (biomedcentral.com)
- Methi F, Telle K, Magnusson K. COVID-19 infection among bartenders and waiters before and after pub lockdown. Occup Environ Med 2022;79(1):46-8.
- Paulsen KM, Vikse R, Soleng A, Edgar K, Elisabeth Heggen Lindstedt H, Dorenberg DH, et al. TBE in Norway. Tick-borne encephalitis - The Book 2022. DOI: 10.33442/26613980_12b24-5
- Ruiz PL, Gunnes N, Gran JM, Karlstad Ø, Selmer R, Dahl J, Bøas H, White RA, Hofman AC, Paulsen TH, Watle SV. Short-term safety of COVID-19 mRNA vaccines with respect to all-cause mortality in the older population in Norway. Vaccine. 2022 Nov 7. https://doi.org/10.1016/j.vaccine.2022.10.085
- Seppälä E, Bråthen Kristoffersen A, Bøås H, Frimann Vestrheim D, Greve-Isdahl M, Freiesleben De Blasio B, et al. Pertussis epidemiology including direct and indirect effects of the childhood pertussis booster vaccinations, Norway, 1998–2019. Vaccine 2022;40(23):3142-9. DOI: 10.1016/j.vaccine.2022.04.038 https://doi.org/10.1016/j.vaccine.2022.04.038
- Severi E, Georgalis L, Pijnacker R, Veneti L et al., incl. Vold L, Herrador Severity of the clinical presentation of hepatitis A in five European countries from 1995 to 2014. Int J Infect Dis. https://doi.org/10.1016/j.ijid.2022.01.053
- Starrfelt J, Danielsen AS, Eirik Alnes B, Juvet LK, Lyngstad TM, Gunnar Øyvind Isaksson R, et al. Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November 2021. BMC Med 2022;20:1-11. DOI: 10.1186/s12916-022-02480-4 Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November 2021 | BMC Medicine | Full Text (biomedcentral.com)
- Starrfelt J, Danielsen AS, Kacelnik O, Wang Børseth A, Seppälä E, Meijerink H. High vaccine effectiveness against coronavirus disease 2019 (COVID-19) and severe disease among residents and staff of long-term care facilities in Norway, November 2020–June 2021. Antimicrobial Stewardship & Healthcare Epidemiology. Cambridge University Press; 2022;2(1): e10. Jan 17. https://doi.org/10.1017/ash.2021.246
- Stebbings S, Rotevatn TA, Vilde Bergstad L, Surén P, Elstrøm P, Greve-Isdahl M, et al. Experience with open schools and preschools in periods of high community transmission of COVID-19 in Norway during the academic year of 2020/2021. BMC Public Health 2022;22:1-9. DOI: 10.1186/s12889-022-13868-5 Experience with open schools and preschools in periods of high community transmission of COVID-19 in Norway during the academic year of 2020/2021 | BMC Public Health | Full Text (biomedcentral.com)
- Størdal K, Paz Lopez-Doriga R, Greve-Isdahl M, Surén P, Knudsen PK, Gulseth HL, et al. Risk factors for SARS-CoV-2 infection and hospitalisation in children and adolescents in Norway: a nationwide population-based study. BMJ Open 2022;12(3). DOI: 10.1136/bmjopen-2021-056549 https://bmjopen.bmj.com/content/12/3/e056549
- Stålcrantz J, Kristoffersen AB, Bøås H, Veneti L, Seppälä E, Aasand N, Hungnes O, Kvåle R, Bragstad K, Buanes EA, Whittaker R. Milder disease trajectory among COVID-19 patients hospitalised with the SARS-CoV-2 Omicron variant compared with the Delta variant in Norway. Scand J Public Health. 2022 Aug;50(6):676-682. doi: 10.1177/14034948221108548. Epub 2022 Jul 7. PMID: 35799474. https://pubmed.ncbi.nlm.nih.gov/35799474/
- Syversen SW, Jyssum I, Tveter AT, Tran TT, Sexton J, Provan SA, et al. Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy. Arthritis & Rheumatology 2022;74(8):1321-32. Immunogenicity and Safety of Standard and Third‐Dose SARS–CoV‐2 Vaccination in Patients Receiving Immunosuppressive Therapy - Syversen - 2022 - Arthritis & Rheumatology - Wiley Online Library
- Tunheim G, Gunnar Øyvind Isaksson R, Tran T, Anne‐Marte Bakken K, Andersen JT, Eline Benno V, et al. Trends in seroprevalence of SARS‐CoV‐2 and infection fatality rate in the Norwegian population through the first year of the COVID‐19 pandemic. Influenza Other Respi Viruses 2022;16(2):204-12. DOI: 10.1111/irv.12932 Trends in seroprevalence of SARS‐CoV‐2 and infection fatality rate in the Norwegian population through the first year of the COVID‐19 pandemic - Tunheim - 2022 - Influenza and Other Respiratory Viruses - Wiley Online Library
- Tønnessen R, García I, Debech N, Lindstrøm JC, Wester AL, Skaare D. Molecular epidemiology and antibiotic resistance profiles of invasive Haemophilus influenzae from Norway 2017–2021. Front Microbiol 2022;13:973257-. DOI: 10.3389/fmicb.2022.973257 Molecular epidemiology and antibiotic resistance profiles of invasive Haemophilus influenzae from Norway 2017-2021 - PubMed (nih.gov)
- Veneti L, Bøås H, Bråthen Kristoffersen A, Stålcrantz J, Bragstad K, Hungnes O, Storm ML, Aasand N, Rø G, Starrfelt J, Seppälä E, Kvåle R, Vold L, Nygård K, Buanes EA, Whittaker R. Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022. Euro Surveill. 2022 Jan;27(4). doi: 10.2807/1560-7917.ES.2022.27.4.2200077. PMID: 35086614. https://pubmed.ncbi.nlm.nih.gov/35086614/
- Whittaker R, Greve-Isdahl M, Bøås H, Suren P, Buanes EA, Veneti L. COVID-19 Hospitalization Among Children <18 Years by Variant Wave in Norway. Pediatrics. 2022 Aug 2:e doi: 10.1542/peds.2022-057564. Epub ahead of print. PMID: 35916036. https://pubmed.ncbi.nlm.nih.gov/35916036/
- Whittaker R, Kristofferson AB, Salamanca BV, Seppälä E, Golestani K, Kvåle R, Watle SV, Buanes EA. Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vaccine to unvaccinated patients. Clin Microbiol 2022 Feb 24:S1198-743X(22)00086-6. doi: 10.1016/j.cmi.2022.01.033. Epub ahead of print. PMID: 35219807. https://pubmed.ncbi.nlm.nih.gov/35219807/
- Örtqvist AK, Magnus MC, Söderling J, Oakley L, Nybo AA-M, Håberg SE, et al. The association between maternal characteristics and SARS-CoV-2 in pregnancy: a population-based registry study in Sweden and Norway. Scientific Reports (Nature Publisher Group) 2022;12(1). DOI: 10.1038/s41598-022-12395- The association between maternal characteristics and SARS-CoV-2 in pregnancy: a population-based registry study in Sweden and Norway | Scientific Reports (nature.com)
2021
- Brandal LT, Ofitserova TS, Meijerink H, Rykkvin R, Lund HM, Hungnes O, Greve-Isdahl M, Bragstad K, Nygård K, Winje BA. Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November 2020. Euro Surveill. 2021 Jan;26(1). doi: 10.2807/1560-7917.ES.2020.26.1.2002011. PMID: 33413743. https://pubmed.ncbi.nlm.nih.gov/33413743/
- Brita Askeland W, Ofitserova TS, Ola Brønstad B, Greve-Isdahl M, Bragstad K, Rykkvin R, et al. Comprehensive Contact Tracing, Testing and Sequencing Show Limited Transmission of SARS-CoV-2 between Children in Schools in Norway, August 2020 to May 2021. Microorganisms 2021;9(12):2587. https://pubmed.ncbi.nlm.nih.gov/34946187/
- Brita Winje B, Vestrheim DF, White RA, Steens A. The Risk of Invasive Pneumococcal Disease Differs between Risk Groups in Norway Following Widespread Use of the 13-Valent Pneumococcal Vaccine in Children. Microorganisms. 2021 Aug 20;9(8):1774. doi: 10.3390/microorganisms9081774. PMID: 34442853.https://pubmed.ncbi.nlm.nih.gov/34442853/
- Cathinka Halle J, Anna Hayman R, Hungnes O, Tunheim G, Bekkevold T, Laake I, et al. Household Transmission of SARS-CoV-2: A Prospective Longitudinal Study Showing Higher Viral Load and Increased Transmissibility of the Alpha Variant Compared to Previous Strains. Microorganisms 2021;9(11):2371. https://pubmed.ncbi.nlm.nih.gov/34835495/
- Danielsen AS, Cyr P-R, Magnus MC, Gravningen KM, Eriksen-Volle H-M, Kacelnik O. Birthing parents had a lower risk of testing positive for SARS-CoV-2 in the peripartum period in Norway, 15th of February 2020 to 15th of May 2021. Infection Prevention in Practice. 2021:100183. https://www.sciencedirect.com/science/article/pii/S259008892100072X
- Eldholm V, Rønning JO, Mengshoel AT, Arnesen T. Import and transmission of Mycobacterium orygis and Mycobacterium africanum, Norway. BMC Infect Dis. 2021 Jun 12;21(1):562. doi: 10.1186/s12879-021-06269-3. PMID: 34118874.https://pubmed.ncbi.nlm.nih.gov/34118874/
- Indseth T, Elgersma IH, Strand BH, Telle K, Labberton AS, Arnesen T, Nygård KM, Godøy A. Covid-19 blant personer født utenfor Norge, justert for yrke, trangboddhet, medisinsk risikogruppe, utdanning og inntekt. Oslo: Folkehelseinstituttet, 2021.https://www.fhi.no/globalassets/dokumenterfiler/rapporter/2021/covid-19-blant-personer-fodt-utenfor-norge-justert-for-yrke-trangboddhet-medisinsk-risikogruppe-utdanning-og-inntekt-rapport-2021.pdf
- Indseth T, Godøy A, Kjøllesdal M, Arnesen T, Carelo CJ, Vinjerui KH, Elgersma IH, Telle K. Covid-19 etter fødeland fra mars 2020 til februar 2021. Oslo: Folkehelseinstituttet, 2021. https://www.fhi.no/globalassets/dokumenterfiler/rapporter/2021/Covid-19-etter-fodeland-fra-mars-2020-til-februar-2021-rapport-2021.pdf
- Indseth T, Grosland M, Arnesen T, Skyrud K, Klovstad H, Lamprini V, et al. COVID-19 among immigrants in Norway, notified infections, related hospitalizations and associated mortality: A register-based study. Scand J Public Health 2021;49(1):48-56. https://pubmed.ncbi.nlm.nih.gov/33406993/
- Indseth T, Nygård KM, Godøy A. Covid-19 blant norskfødte med utenlandsfødte foreldre: Personer testet, bekreftet smittet og relaterte innleggelser. Oslo: Folkehelseinstituttet, 2021. https://www.fhi.no/globalassets/dokumenterfiler/rapporter/2021/covid-19-blant-norskfodte-med-utenlandsfodte-foreldre-personer-testet-bekreftet-smittet-og-relaterte-rapport-2021-v2.pdf
- Johannesen TB, Smeland S, Aaserud S, Buanes EA, Skog A, Ursin G, et al. COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Front Oncol 2021;11:652535. https://pubmed.ncbi.nlm.nih.gov/33842366/
- Katrine Damgaard S, Hernæs KH, Kjetil Elias T, Magnusson K. Impacts of mild COVID-19 on elevated use of primary and specialist health care services: A nationwide register study from Norway. PLoS One 2021;16(10). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500442/
- Kjollesdal M, Skyrud K, Gele A, Arnesen T, Klovstad H, Diaz E, et al. The correlation between socioeconomic factors and COVID-19 among immigrants in Norway: a register-based study. Scand J Public Health 2021:14034948211015860. https://pubmed.ncbi.nlm.nih.gov/33983088/
- Kvåle R, Bønaa KH, Forster R, Gravningen K, Júlíusson PB, Myklebust TÅ. Does a history of cardiovascular disease or cancer affect mortality after SARS-CoV-2 infection? Tidsskr Nor Laegeforen. 2020 Dec 29;140(2). English, Norwegian. doi: 10.4045/tidsskr.20.0956. PMID: 33528146. https://pubmed.ncbi.nlm.nih.gov/33528146/
- Magnus MC, Oakley L, Gjessing HK, Stephansson O, Engjom HM, Macsali F, et al. Pregnancy and risk of COVID-19: a Norwegian registry-linkage study. BJOG 2021. https://pubmed.ncbi.nlm.nih.gov/34657368/
- Molvik M, Danielsen AS, Grøsland M, Telle KE, Kacelnik O, Eriksen-Volle HM. SARS-CoV-2 in health and care staff in Norway, 2020. Tidsskr Nor Laegeforen. 2021 Feb 9;141(3). English, Norwegian. doi: 10.4045/tidsskr.20.1048. PMID: 33624971. https://tidsskriftet.no/en/2021/02/originalartikkel/sars-cov-2-health-and-care-staff-norway-2020
- Nakitanda AO, Montanari L, Tavoschi L, Mozalevskis A, Duffell E. Hepatitis B virus infection in EU/EEA and United Kingdom prisons: a descriptive analysis. Epidemiology & Infection April 2017;145. https://pubmed.ncbi.nlm.nih.gov/33487201/
- Nystad TW, Hufthammer KO, Buanes EA, Bryne K, Fevang BS. COVID-19 in patients with chronic inflammatory rheumatic joint disease. Tidsskr Nor Legeforen 2021 doi: 10.4045/tidsskr.21.0362 2021. https://tidsskriftet.no/en/2021/10/original-article/covid-19-patients-chronic-inflammatory-rheumatic-joint-disease
- Paulsen KM, Vikse R, Soleng A, Edgar KS, Lindstedt HH, Dorenberg DH, Wiklund BS, Andreassen ÅK. TBE in Norway. Chapter 12b. In: Dobler G, Erber W, Bröker M, Schmitt HJ, eds. The TBE Book. 4th ed. Singapore: Global Health Press; 2021. doi:10.33442/26613980_12b24-4 https://www.issuewire.com/the-tbe-book-4th-edition-available-now-1700727362541107 Gratis tilgjengelig, men krever at man registrerer seg her: tbenews.com/tbe
- Seppälä E, Veneti L, Starrfelt J, Danielsen AS, Bragstad K, Hungnes O, Taxt AM, Watle SV, Meijerink H. Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021. Euro Surveill. 2021 Sep;26(35). doi: 10.2807/1560-7917.ES.2021.26.35.2100793. PMID: 34477054. https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2021.26.35.2100793
- Tunheim G, Gunnar Øyvind Isaksson R, Tran T, Anne-Marte Bakken K, Andersen JT, Eline Benno V, et al. Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic. Influenza Other Respi Viruses 2021. https://onlinelibrary.wiley.com/doi/full/10.1111/irv.12932
- Veneti L, Salamanca BV, Seppälä E, Starrfelt J, Storm ML, Bragstad K, Hungnes O, Bøås H, Kvåle R, Vold L, Nygård K, Buanes EA, Whittaker R. No difference in risk of hospitalisation between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway. International Journal of Infectious Diseases, 2021 Dec 11. doi.org/10.1016/j.ijid.2021.12.321. https://www.sciencedirect.com/science/article/pii/S1201971221012182
- Veneti L, Seppälä E, Storm ML, Beatriz Valcarcel S, Eirik Alnes B, Aasand N, et al. Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 –May 2021. PLoS One 2021;16(10).https://pubmed.ncbi.nlm.nih.gov/34634066/
- Vestrheim DF, White RA, Steens A. The Risk of Invasive Pneumococcal Disease Differs between Risk Groups in Norway Following Widespread Use of the 13-Valent Pneumococcal Vaccine in Children. Microorganisms 2021;9(8):1774. https://pubmed.ncbi.nlm.nih.gov/34442853/
- Vilde Bergstad L, Grøsland M, Telle K, Magnusson K. Utilization of health care services before and after media attention about fatal side effects of the AstraZeneca vaccine: a nation-wide register-based event study. BMC Health Serv Res 2021;21:1-10. https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-021-07233-2
- Vinjerui KH, Ingeborg Hess E, Fretheim A. Increased COVID-19 Testing Rates Following Combined Door-to-Door and Mobile Testing Facility Campaigns in Oslo, Norway, a Difference-in-Difference Analysis. Int J Environ Res Public Health 2021;18(21):11078. https://pubmed.ncbi.nlm.nih.gov/34769597/
- Voigt A, Martyushenko N, Karlsen E, Hall M, Nyhamar K, Omholt SW, et al. Containing pandemics through targeted testing of households. BMC Infect Dis 2021;21:1-10. https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-021-06256-8
2020
- Anna Hayman R, Mahic M, Savic M, Tunheim G, Hungnes O, Lill T, et al. Detection of anti‐NS1 antibodies after pandemic influenza exposure: Evaluation of a serological method for distinguishing H1N1pdm09 infected from vaccinated cases. Influenza Other Respi Viruses 2020;14(3):294-https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182603/ .
- Gulseth HL, Helland E, Johansen KI, Gravningen K, Eide HN, Håberg SE, Bakken IJ. Dødsfall etter påvist sars-CoV-2 i Norge. Tidsskr Nor legeforen 2020, doi: 10.4045/tidsskr.20.0693. https://tidsskriftet.no/2020/12/originalartikkel/dodsfall-etter-pavist-sars-cov-2-i-norge
- Gunnes N, Gjessing HK, Bakken IJ, Ghaderi S, Gran JM, Hungnes O, et al. Seasonal and pandemic influenza during pregnancy and risk of fetal death: A Norwegian registry-based cohort study. Eur J Epidemiol 2020;35(4):371- 9. https://pubmed.ncbi.nlm.nih.gov/31950373/
- Gunnes N, Gjessing HK, Bakken IJ, Ghaderi S, Gran JM, Hungnes O, Magnus P, Samuelsen SO, Skrondal A, Stoltenberg C, Trogstad L, Wilcox AJ, Håberg SE. Seasonal and pandemic influenza during pregnancy and risk of fetal death: A Norwegian registry-based cohort study. Eur J Epidemiol. 2020 Jan 16. [Epub ahead of print]. PMID: 31950373. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192880/
- Johansen TB, Astrup E, Jore S, Nilssen H, Dahlberg BB, Klingenberg C, Berg AS, Greve-Isdahl M. Infection prevention guidelines and considerations for paediatric risk groups when reopening primary schools during COVID-19 pandemic, Norway, April 2020. Eurosurveill 2020;25(22):2000921. https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.22.2000921
- Kuhn KG, Nygård KM, Guzman-Herrador B, Sunde Linda S, Rimhanen-Finne R, Trönnberg L, et al. Campylobacter infections expected to increase due to climate change in Northern Europe. Scientific Reports (Nature Publisher Group) 2020;10(1). https://pubmed.ncbi.nlm.nih.gov/32807810/
- Løchen A, Croucher NJ, Anderson RM. Divergent serotype replacement trends and increasing diversity in pneumococcal disease in high income settings reduce the benefit of expanding vaccine valency. Scientific Reports (Nature Publisher Group) 2020;10(1. https://www.nature.com/articles/s41598-020-75691-5
- Nystad W, Hjellvik V, Larsen IK, Ariansen I, Helland E, Johansen KI, Gulbrandsen J, Gulseth HL, Eide HN, Håberg SE, Karlstad Ø. Underliggende tilstander hos voksne med covid-19. Tidsskrift for Den norske legeforening. 2020 Sep doi: 10.4045/tidsskr.20.0512. https://tidsskriftet.no/2020/09/originalartikkel/underliggende-tilstander-hos-voksne-med-covid-19
- Osnes MN, Didelot X, Korne-Elenbaas J, Alfsnes K, Brynildsrud OB, Syversen G, Nilsen ØJ, De Blasio BF, Caugant DA, Eldholm Sudden emergence of a Neisseria gonorrhoeae clade with reduced susceptibility to extended-spectrum cephalosporins, Norway. MicrobGenom. 2020 Nov 17. doi: 10.1099/mgen.0.000480. Epub ahead of print. PMID: 33200978. https://pubmed.ncbi.nlm.nih.gov/33200978/
- Seppälä E, Tønnessen R, Veneti L, Paulsen TH, Steens A, Whittaker R, Bragstad K, Berild JD, Løvlie AL, Naseer U, MacDonald E, Vold L. Covid-19 rapporterttil Folkehelseinstituttet de førsteseksukene av epidemien. Tidsskr Nor Legeforen 2020 11 Desember doi: 10.4045/tidsskr.20.0525. https://tidsskriftet.no/2020/12/originalartikkel/covid-19-rapportert-til-folkehelseinstituttet-de-forste-seks-ukene-av
- Siira L, Vestrheim DF, Winje BA, Caugant DA, Steens A. Antimicrobial susceptibility and clonality of Streptococcus pneumoniae isolates recovered from invasive disease cases during a period with changes in pneumococcal childhood vaccination, Norway, 2004-2016. Vaccine 2020;38(34):5454-63. https://pubmed.ncbi.nlm.nih.gov/32616324/
- Stefanoff P, Lovlie AL, Elstrom P, Macdonald EA. Reporting of notifiable infectious diseases during the COVID-19 response. Tidsskr Nor Laegeforen 2020;140(9):16. https://pubmed.ncbi.nlm.nih.gov/32549020/
- Stordal K, Bakken IJ, Greve-Isdahl M, Klingenberg C, Helland E, Nystad W, et al. SARS-CoV-2 in children and adolescents in Norway: confirmed infection, hospitalisations and underlying conditions. Tidsskr Nor Laegeforen 2020;140(11):18. https://tidsskriftet.no/en/2020/07/originalartikkel/sars-cov-2-children-and-adolescents-norway-confirmed-infection
- Whittaker R, Case KK, Nilsen Ø, Blystad H, Cowan S, Kløvstad H, et al. Monitoring progress towards the first UNAIDS 90-90-90 target in key populations living with HIV in Norway. BMC Infect Dis 2020;20:1-11 https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-020-05178-1
- Whittaker R, Grøsland M, Buanes EA, Beitland S, Bryhn B, Helgeland J, Sjøflot,OI, Berild JD, Seppälä E, Tønnessen R, Telle K. Sykehusinnleggelser med covid-19 ‒ en sammenligning av ulike datakilder. Tidsskr Nor Legeforen 2020 14 Desember doi: 10.4045/tidsskr.20.0759. https://tidsskriftet.no/2020/12/originalartikkel/sykehusinnleggelser-med-covid-19-en-sammenligning-av-ulike-datakilder
- Whittaker R, Nilsen Ø, Myrberg AJ, Angeltvedt RM, Bergersen BM, Kløvstad H. Norge er i ferd med å stanse hivepidemien. Kronikk. Tidsskr Nor Legeforen 2020, Des 01. https://tidsskriftet.no/2020/11/kronikk/norge-er-i-ferd-med-stanse-hivepidemien
2019
- Danielsen AS, Elstrom P, Arnesen TM, Gopinathan U, Kacelnik O. Targeting TB or MRSA in Norwegian municipalities during 'the refugee crisis' of 2015: a framework for priority setting in screening. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 2019;24(38). https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2019.24.38.1800676
- Elstrom P, Astrup E, Hegstad K, Samuelsen O, Enger H, Kacelnik O. The fight to keep resistance at bay, epidemiology of carbapenemase producing organisms (CPOs), vancomycin resistant enterococci (VRE) and methicillin resistant Staphylococcus aureus (MRSA) in Norway, 2006- 2017. PLoS ONE 2019;14 (2) (no pagination)(e0211741). https://pubmed.ncbi.nlm.nih.gov/30716133/
- Elstrom P, Grontvedt CA, Gabrielsen C, Stegger M, Angen O, Amdal S, et al. Livestock-Associated MRSA CC1 in Norway; Introduction to Pig Farms, Zoonotic Transmission, and Eradication. Frontiers in Microbiology 2019;10 (FEB) (no pagination)(139). https://www.frontiersin.org/articles/10.3389/fmicb.2019.00139/full
- Jenssen GR, Veneti L, Lange H, Vold L, Naseer U, Brandal LT. Implementation of multiplex PCR diagnostics for gastrointestinal pathogens linked to increase of notified Shiga toxin-producing Escherichia coli cases in Norway, 2007-2017. European Journal of Clinical Microbiology and Infectious Diseases 2019;38(4):801-9. https://pubmed.ncbi.nlm.nih.gov/30680573/
- MacDonald E, White R, Mexia R, Bruun T, Kapperud G, Brandal LT, et al. The role of domestic reservoirs in domestically acquired Salmonella infections in Norway: Epidemiology of salmonellosis, 2000-2015, and results of a national prospective case-control study, 2010-2012. Epidemiology and Infection 2019;147 (no pagination)(e43). https://pubmed.ncbi.nlm.nih.gov/30428947/
- Pettersson JHO, Myking S, Elshaug H, Bygdas KIE, Stene-Johansen K. Molecular epidemiology of hepatitis B virus infection in Norway. BMC Infect Dis 2019;19 (1) (no pagination)(236). https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-019-3868-8
- Steens A, Winje BA, White RA, Odsbu I, Brantsaeter AB, Vestrheim DF. Indirect effects of pneumococcal childhood vaccination in individuals treated with immunosuppressive drugs in ambulatory care: A case-cohort study. Clin Infect Dis 2019;68(8):1367-73. https://pubmed.ncbi.nlm.nih.gov/30957160/
- Tunheim G, Laake I, Anna Hayman R, Waalen K, Hungnes O, Næss LM, et al. Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self‐reported severity and duration of illness. Influenza and Other Respiratory Viruses 2019;13(2):191-200. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379636/
- Winje BA, Groneng GM, White RA, Akre P, Aavitsland P, Heldal E. Immigrant screening for latent tuberculosis infection: Numbers needed to test and treat, a Norwegian population-based cohort study. BMJ Open 2019;9 (1) (no pagination)(e023412). https://pubmed.ncbi.nlm.nih.gov/30782706/
- Wolff C, Lange H, Feruglio S, Vold L, MacDonald E. Evaluation of the national surveillance of Legionnaires' disease in Norway, 2008-2017. BMC public health 2019;19(1):1624. https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-019-7981-9
- Siira L, Naseer U, Alfsnes K, Hermansen NO, Lange H, Brandal LT. Whole genome sequencing of Salmonella Chester reveals geographically distinct clusters, Norway, 2000 to 2016. Euro Surveill 2019;24(4). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352000/
2018
Ruiz PLD, Tapia G, Bakken IJ, Hasberg SE, Hungnes O, Gulseth HL, et al. Pandemic influenza and subsequent risk of type 1 diabetes: a nationwide cohort study. Diabetologia 2018;61(9):1996-2004. https://www.ncbi.nlm.nih.gov/pubmed/29934759
Laake I, Tunheim G, Anna Hayman R, Hungnes O, Waalen K, Håberg SE, et al. Risk of pregnancy complications and adverse birth outcomes after maternal A(H1N1)pdm09 influenza: a Norwegian population-based cohort study. BMC Infect Dis 2018;18. https://www.ncbi.nlm.nih.gov/pubmed/30348103
MacDonald E, White R, Mexia R, Bruun T, Kapperud G, Brandal LT, et al. The role of domestic reservoirs in domestically acquired Salmonella infections in Norway: epidemiology of salmonellosis, 2000-2015, and results of a national prospective case-control study, 2010-2012. Epidemiol Infect 2018:1-8. https://www.ncbi.nlm.nih.gov/pubmed/30428947
Winje BA, White R, Syre H, Skutlaberg DH, Oftung F, Mengshoel AT, et al. Stratification by interferon- release assay level predicts risk of incident TB. Thorax 2018;73(7):652-61. https://www.ncbi.nlm.nih.gov/pubmed/29622693
Gounder PP, Koch A, Provo G, Lovlie A, Ederth JL, Axelsson M, et al. Summary of available surveillance data on hepatitis C virus infection from eight Arctic countries, 2012 to 2014 separator. Eurosurveillance 2018;23(40). https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2018.23.40.1700408
Mysterud A, Vetle Malmer S, Seland IV, Herland A, Easterday WR, Jore S, et al. Tick abundance, pathogen prevalence, and disease incidence in two contrasting regions at the northern distribution range of Europe. Parasites & Vectors 2018;11. https://www.ncbi.nlm.nih.gov/pubmed/29788994
Schein YL, Madebo T, Andersen HE, Arnesen TM, Dyrhol-Riise AM, Tveiten H, et al. Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study. BMC Infect Dis 2018;18(1):587. https://www.ncbi.nlm.nih.gov/pubmed/30453946
Johansen TB, Scheffer L, Jensen VK, Bohlin J, Feruglio SL. Whole-genome sequencing and antimicrobial resistance in Brucella melitensis from a Norwegian perspective. Scientific Reports (Nature Publisher Group) 2018;8:1-9. https://www.ncbi.nlm.nih.gov/pubmed/29559127
Beauté J, Westrell T, Schmid D, Müller L, Epstein J, Kontio M, Couturier E, Faber M, Mellou K, Borg ML, Friesema I, Vold L, Severi E. Travel-associated hepatitis A in Europe, 2009 to 2015. Euro Surveill 2018;23(22). https://doi.org/10.2807/1560-7917.ES.2018.23.22.1700583
Riise ØR, Laake I, Vestrheim D, Winje BA, Moster D, Storsæter J. Preterm Children Have Higher Risk Than Full-Term Children of Invasive Pneumococcal Disease During the First Two Years of Life. Pediatr Infect Dis J 2018; Mar 21. doi: 10.1097/INF.0000000000001989. [Epub ahead of print]. https://journals.lww.com/pidj/Abstract/publishahead/Preterm_Children_Have_Higher_Risk_Than_Full_Term.96693.aspx
Steens A, Winje BA, White RA, Odsbu I, Brantsaeter AB, Vestrheim DF. Indirect effects of pneumococcal childhood vaccination in individuals treated with immunosuppressants in ambulatory care: a case-cohort study. Clinical Infectious Diseases 2018 Aug 25. [Epub ahead of print].
https://www.ncbi.nlm.nih.gov/pubmed/30957160
Veneti L, Borgen K, Borge KS, Dansi K, Greve-Isdahl M, Konsmo K, Njølstad G, Nordbø SA, Øystese KS, Rykkvin R, Sagvik E, Riise ØR. Large outbreak of mumps virus genotype G among vaccinated students in Norway, 2015 to 2016. Euro Surveill 2018;23(38). ES.2018.23.38.1700642. https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2018.23.38.1700642
2017
Andreassen AES, Jacobsen CM, de Blasio B, White R, Kristiansen IS, Elstrom P. The impact of methicillin-resistant S. aureus on length of stay, readmissions and costs: a register based case-control study of patients hospitalized in Norway. Antimicrob 2017;6:74
Blomfeldt A, Larssen KW, Moghen A, Gabrielsen C, Elstrom P, Aamot HV, et al. Emerging multidrug-resistant Bengal Bay clone ST772-MRSA-V in Norway: molecular epidemiology 2004-2014. European Journal of Clinical Microbiology and Infectious Diseases 2017;36(10):1911-21.
Egenberg HEI, Henriette; Karlsrud, Anniken; Weisser, Kristin Howlid; Ødegård, Marianne Meier; Majeed, Heidi Vego. Pneumokokkvaksinasjon av eldre på sykehjem. Et kvalitetsforbedringsprosjekt ved Modumheimen Sykehjem [Master thesis]: Universitet i Oslo; 2017.
Francesco Di R, Bjørnholt JV, Leegaard TM, Fossum Moen AE, Birgitte Freiesleben de B. MRSA infections in Norway: A study of the temporal evolution, 2006-2015. PLoS One 2017;12(6).
Haukaas FS, Arnesen TM, Winje BA, Aas E. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis. The European Journal of Health Economics : HEPAC 2017;18(4):405-15.
Lill T, Bakken IJ, Gunnes N, Ghaderi S, Stoltenberg C, Magnus P, et al. Narcolepsy and hypersomnia in Norwegian children and young adults following the influenza A(H1N1) 2009 pandemic. Vaccine 2017;35(15):1879-85.
Meijerink H, White RA, Lovlie A, Birgitte Freiesleben de B, Dalgard O, Amundsen EJ, et al. Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973-2030. BMC Infect Dis 2017;17.
Mysterud A, Jore S, Østerås O, Viljugrein H. Emergence of tick-borne diseases at northern latitudes in Europe: a comparative approach. Scientific Reports (Nature Publisher Group) 2017;7:1-12.
PÄRn T, Dahl V, Lienemann T, Perevoscikovs J, De Jong B. Multi-country outbreak of Salmonella enteritidis infection linked to the international ice hockey tournament. Epidemiology and Infection 2017;145(11):2221-30.
Samuelsen Ø, Overballe-Petersen S, Bjørnholt JV, Brisse S, Doumith M, Woodford N, et al. Molecular and epidemiological characterization of carbapenemase-producing Enterobacteriaceae in Norway, 2007 to 2014. PLoS One 2017;12(11).
Årdal C, Blix HS, Plahtea J, Røttingen J-A. An antibiotic's journey from marketing authorization to use, Norway/Parcours d'un antibiotique, de son autorisation de mise sur le marché à son utilisation, en Norvège/El recorrido de un antibiótico desde la autorización de comercialización a su uso en Noruega. World Health Organization Bulletin of the World Health Organization 2017;95(3):220-6.
2016
Abitbol, C. L., & Moxey-Mims, M. (2016). Chronic kidney disease: Low birth weight and the global burden of kidney disease. Nature Reviews Nephrology, 12(4), 199-200. doi:https://dx.doi.org/10.1038/nrneph.2016.19
Bourgeois, A. C., Zulz, T., Soborg, B., Koch, A., & International Circumpolar Surveillance--Tuberculosis Working, G. (2016). Descriptive review of tuberculosis surveillance systems across the circumpolar regions. International Journal of Circumpolar Health, 75, 30322. doi:https://dx.doi.org/10.3402/ijch.v75.30322
Guzman-Herrador, B., de Blasio, B. F., Lund, V., MacDonald, E., Vold, L., Wahl, E., & Nygard, K. (2016). [Waterborne outbreaks in Norway 2003-2012]. Tidsskrift for den Norske Laegeforening, 136(7), 612-616. doi:https://dx.doi.org/10.4045/tidsskr.15.0114
MacDonald, E., Einoder-Moreno, M., Borgen, K., Brandal, L. T., Diab, L., Fossli, O., . . . Nygard, K. (2016). National outbreak of Yersinia enterocolitica infections in military and civilian populations associated with consumption of mixed salad, Norway, 2014. Eurosurveillance, 21(34), 11-19. doi:10.2807/1560-7917.es.2016.21.34.30321
MacDonald, E., Vestrheim, D. F., White, R. A., Konsmo, K., Lange, H., Aase, A., . . . Vold, L. (2016). Are the current notification criteria for Lyme borreliosis in Norway suitable? Results of an evaluation of Lyme borreliosis surveillance in Norway, 1995-2013. BMC Public Health, 16, 729. doi:https://dx.doi.org/10.1186/s12889-016-3346-9
Midgard, H., Bramness, J. G., Skurtveit, S., Haukeland, J. W., & Dalgard, O. (2016). Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study. PloS One, 11(11), e0166451. doi:https://dx.doi.org/10.1371/journal.pone.0166451
Nguipdop-Djomo, P., Heldal, E., Rodrigues, L. C., Abubakar, I., & Mangtani, P. (2016). Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study. The Lancet Infectious Diseases, 16(2), 219-226. doi: https://dx.doi.org/10.1016/S1473-3099(15)00400-4
2015
Arnesen, T. M., Seterelv, S., Norheim, G., Helgebostad, S. R., Mannsaker, T., Ly, I. N., . . . Steen, T. W. (2015). Tuberculosis outbreak in Eastern Norway. Tidsskrift for den Norske Laegeforening, 135(23-24), 2160-2164.
Guzman Herrador, B. R., Ronning, K., Borgen, K., Mannsaker, T., & Dahle, U. R. (2015). Description of the largest cluster of tuberculosis notified in Norway 1997-2011: is the Norwegian tuberculosis control programme serving its purpose for high risk groups? BMC Public Health, 15, 367.
Klovstad, H., & Aavitsland, P. (2015). Denominators count: supplementing surveillance data for genital Chlamydia trachomatis infection with testing data, Norway, 2007 to 2013. Eurosurveillance, 20(36), 20-27.
MacDonald, E., White, R., Mexia, R., Bruun, T., Kapperud, G., Lange, H., . . . Vold, L. (2015). Risk Factors for Sporadic Domestically Acquired Campylobacter Infections in Norway 2010-2011: A National Prospective Case-Control Study. PLoS ONE [Electronic Resource], 10(10), e0139636.
Magnus, P., Gunnes, N., Tveito, K., Bakken, I. J., Ghaderi, S., Stoltenberg, C., . . . Haberg, S. E. (2015). Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine. Vaccine, 33(46), 6173-6177.
Munson, S., Raluy-Callado, M., Lambrelli, D., Wasiak, R., Eriksson, D., & Gray, S. (2015). Clinical burden of pneumonia, meningitis and septicemia in Norway 2 years after 7-valent pneumococcal conjugate vaccine introduction. Scandinavian Journal of Public Health, 43(6), 657-666.
Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine. Magnus, P., Gunnes, N., Tveito, K., Bakken, I. J., Ghaderi, S., Stoltenberg, C., Haberg, S. E. (2015). Vaccine, 33(46), 6173-6177.
MSIS fyller 40 år. A Løvlie, H Blystad, T Bruun. Nr. 23/24 – 15. desember 2015. Tidsskr Nor Legeforen. 2015; 135:2136 – 7. http://www.ncbi.nlm.nih.gov/pubmed/26674030
2014
Haugum, K., Brandal, L. T., Lindstedt, B. A., Wester, A. L., Bergh, K., & Afset, J. E. (2014). PCR-based detection and molecular characterization of shiga toxin-producing Escherichia coli strains in a routine microbiology laboratory over 16 years. Journal of Clinical Microbiology, 52(9), 3156-3163.
Jakopanec, I., Grjibovski, A. M., Nilsen, O., Blystad, H., & Aavitsland, P. (2013). Trends in HIV infection surveillance data among men who have sex with men in Norway, 1995-2011. BMC public health, 13, 144.
Jenssen, G. R., Hovland, E., Bjerre, A., Bangstad, H. J., Nygard, K., & Vold, L. (2014). Incidence and etiology of hemolytic-uremic syndrome in children in Norway, 1999-2008-a retrospective study of hospital records to assess the sensitivity of surveillance. BMC Infectious Diseases, 14, 9.
Larssen, K. W., Bergh, K., Heier, B. T., Vold, L., & Afset, J. E. (2014). All-time high tularaemia incidence in Norway in 2011: report from the national surveillance. European Journal of Clinical Microbiology & Infectious Diseases, 33(11), 1919-1926.
Riviere, J., Carabin, K., Le Strat, Y., Hendrikx, P., & Dufour, B. (2014). Bovine tuberculosis surveillance in cattle and free-ranging wildlife in EU Member States in 2013: A survey-based review. Veterinary Microbiology, 173(3-4), 323-331.
Riviere, J., Strat, Y. l., Hendrikx, P., & Dufour, B. (2014). Bovine tuberculosis surveillance in cattle and free-ranging wildlife in European Union Member States in 2013: a survey-based review. Epidemiologie et Sante Animale, 66, 117-132.
2013
Sagbakken, M., Frich, J. C., Bjune, G. A., & Porter, J. D. (2013). Ethical aspects of directly observed treatment for tuberculosis: A cross-cultural comparison. BMC Medical Ethics, 14, 25.
Status of infectious diseases in Europe. Report of the European centre for disease prevention and control (ECDC). (2013). Boletin Epidemiologico Semanal, 21(2), 14-15.
2012
Surveillance of travel-associated gastrointestinal infections in Norway, 2009-2010: Are they all actually imported? Guzman-Herrador B., Vold L., Nygard K. Embase Eurosurveillance. 17 (41) , 2012. Date of Publication: 11 Oct 2012.
Phenotypic and genotypic properties of Neisseria gonorrhoeae isolates in Norway in 2009: Antimicrobial resistance warrants an immediate change in national management guidelines.
Hjelmevoll S.O., Golparian D., Dedi L., Skutlaberg D.H., Haarr E., Christensen A., Jorgensen S., Nilsen O.J., Unemo M., Skogen V. Embase European Journal of Clinical Microbiology and Infectious Diseases. 31 (6) (pp 1181-1186), 2012. Date of Publication: June 2012.
Usefulness of health registries when estimating vaccine effectiveness during the influenza A(H1N1)pdm09 pandemic in Norway. Guzman Herrador B.R., Aavitsland P., Feiring B., Riise Bergsaker M.A., Borgen K. Embase BMC infectious diseases. 12 (pp 63), 2012. Date of Publication: 2012.
2011
Meticillin-resistant Staphylococcus aureus in Norway, a low-incidence country, 2006-2010. Elstrøm P, Kacelnik O, Bruun T, Iversen B, Hauge SH, Aavitsland P. Department of Infectious Disease Epidemiology, Norwegian Institute of Public Health, Oslo, Norway. J Hosp Infect. 2012 Jan;80(1):36-40. doi: 10.1016/j.jhin.2011.10.004. Epub 2011 Nov 25.
Epidemiology of acute and chronic hepatitis B virus infection in Norway, 1992-2009. BMC Infect Dis. 2011; 11: 153. Published online 2011 May 26. doi: 10.1186/1471-2334-11-153. Gražina Rimšelienė, Øivind Nilsen, Hilde Kløvstad,Hans Blystad, and Preben Aavitsland
Gonoré – på tide med nye retningslinjer Tidsskr Nor Laegeforen. 2011 Apr 8;131(7):671-2. doi: 10.4045/tidsskr.10.1380. Hartgill U, Jakopanec I, Vestrheim DF.
Childhood tuberculosis in the European Union/European Economic Area, 2000 to 2009. Sandgren A. Hollo V. Quinten C. Manissero D. Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R) Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin. 16(12), 2011. UI: 21457686
2010
Syphilis epidemiology in Norway, 1992-2008: Resurgence among men who have sex with men. Jakopanec I., Grjibovski A.M., Nilsen O., Aavitsland P. Embase BMC Infectious Diseases. 10 , 2009. Article Number: 105. Date of Publication: 29 Apr 2010.
Evidence for waning of latency in a cohort study of tuberculosis. Wiker H.G., Mustafa T., Bjune G.A., Harboe M. Embase BMC infectious diseases. 10 (pp 37), 2010. Date of Publication: 2010.
Screening and treatment of latent tuberculosis in a cohort of asylum seekers in Norway. Harstad I., Heldal E., Steinshamn S.L., Garasen H., Winje B.A., Jacobsen G.W. Embase Scandinavian journal of public health. 38 (3) (pp 275-282), 2010. Date of Publication: May 2010.
Evidence for waning of latency in a cohort study of tuberculosis. Wiker H.G., Mustafa T., Bjune G.A., Harboe M. Embase BMC Infectious Diseases. 10 , 2010. Article Number: 37. Date of Publication: 23 Feb 2010.
The role of entry screening in case finding of tuberculosis among asylum seekers in Norway. Harstad I., Jacobsen G.W., Heldal E., Winje B.A., Vahedi S., Helvik A.S., Steinshamn S.L., Garasen H. Embase BMC public health. 10 (pp 670), 2010. Date of Publication: 2010.
2009
The epidemiology of gonorrhoea in Norway, 1993-2007: past victories, future challenges. Jakopanec I., Borgen K., Aavitsland P. Embase BMC infectious diseases. 9 (pp 33), 2009. Date of Publication: 2009.
Surveillance and prevalence of antimicrobial resistance in Norway. <Overvaking og forekomst av antibiotikaresistens i Norge.> Simonsen G.S. Embase Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 129 (7) (pp 623-627), 2009. Date of Publication: 26 Mar 2009.
Tuberculosis screening and follow-up of asylum seekers in Norway: a cohort study. Harstad I., Heldal E., Steinshamn S.L., Garasen H., Jacobsen G.W. Embase BMC public health. 9 (pp 141), 2009. Date of Publication: 2009.
Tuberculosis in the EU and EEA/EFTA countries: what is the latest data telling us? Hollo V., Amato-Gauci A., Kodmon C., Manissero D.
Embase Euro surveillance : bulletin europeen sur les maladies transmissibles = European communicable disease bulletin. 14 (11) , 2009. Date of Publication: 2009.
2008
An exploratory study of disease surveillance systems in Norway. Johansen M.A., Scholl J., Aronsen G., Hartvigsen G., Bellika J.G. Embase Journal of telemedicine and telecare. 14 (7) (pp 368-371), 2008. Date of publication: 2008.
AIDS-related primary central nervous system lymphoma: a Norwegian national survey 1989-2003. Haldorsen I.S., Krakenes J., Goplen A.K., Dunlop O., Mella O., Espeland A. Embase BMC cancer. 8 (pp 225), 2008. Date of Publication: 2008.
Should children adopted from abroad be screened for methicillin-resistant Staphylococcus aureus? <Bor barn adoptert fra utlandet undersøkes for meticillinresistente stafylokokker?.> Elstrom P., Iversen B., Aavitsland P. Embase Tidsskrift for den Norske laegeforening. 128 (3) (pp 291-293), 2008. Date of Publication: 31 Jan 2008.
Meticillinresistente gule stafylokokker i Norge Petter Elstrøm, Preben Aavitsland Tidsskr Nor Legeforen nr. 23, 2008; 128: 2730–3
Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vestrheim D.F., Lovoll O., Aaberge I.S., Caugant D.A., Hoiby E.A., Bakke H., Bergsaker M.R. Embase Vaccine. 26 (26) (pp 3277-3281), 2008. Date of Publication: 19 Jun 2008.
International Circumpolar Surveillance System for invasive pneumococcal disease, 1999-2005. Bruce MG. Deeks SL. Zulz T. Bruden D. Navarro C. Lovgren M. Jette L. Kristinsson K. Sigmundsdottir G. Jensen KB. Lovoll O. Nuorti JP. Herva E. Nystedt A. Sjostedt A. Koch A. Hennessy TW. Parkinson AJ. Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R). Emerging Infectious Diseases. 14(1):25-33, 2008 Jan. [Journal Article. Research Support, Non-U.S. Gov't. Research Support, U.S. Gov't, P.H.S.] UI: 18258073
Drug resistance in tuberculosis. <Medikamentresistens ved tuberkulose.> Winje B.A., Mannsaker T., Langeland N., Heldal E. Embase Tidsskrift for den Norske Laegeforening. 128 (22) (pp 2588-2592), 2008. Date of Publication: 20 Nov 2008.
2007
Ingen publikasjoner
2006
Incidence trend and risk factors for campylobacter infections in humans in Norway. Marianne Sandberg, Karin Nygård, Hege Meldal, Paul Steinar Valle, Hilde Kruse and Eystein Skjerve BMC Public Health 2006, 6:179
A large community outbreak of waterborne giardiasis-delayed detection in a non-endemic urban area. Karin Nygård, Barbara Schimmer, Øystein Søbstad, Anna Walde, Ingvar Tveit, Nina Langeland, Trygve Hausken and Preben Aavitsland BMC Public Health 2006, 6:141
